What is the recommended treatment for a patient with cat scratch fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Cat Scratch Fever

Azithromycin is the first-line treatment for cat scratch disease, dosed at 500 mg on day 1 followed by 250 mg daily for 4 additional days in patients >45 kg, or 10 mg/kg on day 1 and 5 mg/kg daily for 4 more days in patients <45 kg. 1

Treatment Algorithm

For Immunocompetent Patients with Typical Cat Scratch Disease

First-line therapy:

  • Azithromycin is recommended by the American College of Physicians based on placebo-controlled evidence showing more rapid reduction in lymph node size 1
  • This recommendation is supported by the only placebo-controlled study demonstrating clinical benefit 1, 2
  • Most cases are self-limited and resolve within 1-6 months without treatment, but antibiotics accelerate recovery 1, 3

Alternative regimens if azithromycin is contraindicated:

  • Doxycycline 100 mg twice daily for 10-14 days (CDC recommendation) 1, 4
  • Erythromycin 500 mg four times daily 1
  • For children <45 kg: doxycycline 2.2 mg/kg twice daily (max 100 mg/dose) for 10-14 days 4

For Severe or Disseminated Disease

When to treat aggressively:

  • Extranodal or disseminated disease (occurs in ≤2% of cases) 1
  • Hepatosplenic involvement 1, 5
  • CNS involvement 1
  • Any immunocompromised patient 1

Preferred regimens for severe disease:

  • Gentamicin shows 73% efficacy with rapid response within 48 hours for hepatosplenic involvement 1, 5
  • Doxycycline with or without rifampin is the CDC's treatment of choice for CNS bartonellosis and other severe infections 1

For Immunocompromised Patients (Especially HIV/AIDS)

Critical considerations:

  • Up to 25% of culture-positive HIV patients with CD4+ <100 cells/µL may never develop antibodies 1
  • Consider Bartonella in any HIV patient with unexplained fever and CD4+ <100 cells/µL 1
  • Evaluate for bacillary angiomatosis (cutaneous vascular lesions mimicking Kaposi's sarcoma) 1

Treatment regimen:

  • Erythromycin or doxycycline for more than 3 months for bacillary angiomatosis, peliosis hepatis, or CNS involvement 1
  • Long-term suppression with erythromycin or doxycycline until CD4+ >200 cells/µL for >6 months to prevent relapse 1

Special Populations

Pregnant women:

  • Erythromycin is the only safe option - tetracyclines (doxycycline) are completely contraindicated 1
  • Use erythromycin for both acute treatment and long-term suppression if needed 1

Children:

  • Same azithromycin regimen with weight-based dosing: 10 mg/kg day 1, then 5 mg/kg for 4 days if <45 kg 1, 6
  • Fluoroquinolones should be used with extreme caution and only if no alternatives exist 1

Common Pitfalls and Caveats

Antibiotics to AVOID:

  • Penicillins and first-generation cephalosporins have no in vivo activity and should never be used 1
  • Quinolones and TMP-SMX have variable activity and inconsistent clinical response - not recommended by CDC 1
  • Note: This contradicts older retrospective data showing ciprofloxacin efficacy 7, 5, but current CDC guidelines do not recommend fluoroquinolones 1

Diagnostic timing issues:

  • Serologic testing may not show detectable antibodies until 6 weeks after acute infection 1
  • Do not delay treatment waiting for serology in clinically suspected cases 1
  • Do not test cats for Bartonella - this provides no benefit to diagnosis or management 1

When NOT to treat:

  • Most immunocompetent patients with typical lymphadenopathy can be managed conservatively without antibiotics 3
  • Lymphadenopathy generally resolves within 1-6 months spontaneously 1
  • Treatment is primarily indicated for symptom acceleration, immunocompromised patients, or severe/disseminated disease 1

Monitoring and Follow-Up

  • Suppuration occurs in approximately 10% of cases and may require drainage 1
  • For immunocompromised patients on long-term suppression, continue until immune reconstitution (CD4+ >200 cells/µL for >6 months) 1
  • Serial imaging may be needed for hepatosplenic involvement - lesions can take 4 months to resolve even with appropriate treatment 8

References

Guideline

Treatment of Cat Scratch Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of cat-scratch disease.

Current opinion in pediatrics, 2001

Research

Cat-scratch Disease.

American family physician, 2011

Guideline

Management of Cat Scratch Injuries

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Guidance for Cat Scratch Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Disseminated cat-scratch disease: case report and review of the literature.

Paediatrics and international child health, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.